May 28 – 29, 2026 | Eurostars Thalia | Prague
Learn how leaders from Novartis, GSK and Merck solve real portfolio challenges.
Most pharma portfolios don’t fail due to lack of strategy — but due to misalignment, poor visibility and execution gaps.
Decisions take too long
Portfolio reviews drag on for weeks, delaying critical investments and slowing down execution.
Politics over data
Priorities are shaped by internal influence rather than real portfolio value and impact.
Disconnected from delivery
Governance models look solid on paper but fail when faced with real project constraints.
Real case studies, proven frameworks and decision-making approaches used by leading pharma companies.
Why portfolio visibility often fails — and how leaders improve transparency across complex organisations.
Global Head of Strategy and Portfolio Management, Data & Digital Novartis Research
Novartis
How to turn portfolio strategy into measurable results — from KPIs to execution.
Head, Global Portfolio and Project Management
Takeda
Where portfolio leaders lose time in study design, start-up and execution — and how to fix it.
Senior Project and Portfolio Manager
Menarini Biotech
Using AI to Improve Portfolio Execution.
Exec Dir R&D Project & Portfolio Management
CSL Behring
See all sessions, speakers and topics
Watch selected sessions and insights from previous editions.
Meet the people deciding which projects move forward — and which don’t.
Executive Spotlight
Roundtable Discussions
Panel Discussions
Case Study Sessions
Leadership Circle
In the Hot Seat
Expert Interviews
Interactive Sessions
Workshops
What-If Lab
150+
Pharma Attendees
30+
Speakers
2
Inspiring Days
Be part of a focused community discussing how to manage complex pharmaceutical project portfolios.
See the full 2-day programme, featured speakers, and the key topics shaping discussions at Pharma PPM Toolbox.
Get access to the rest of the video, including the key insights and practical takeaways.
